AFFECT-EU (2020-2024) focused on digital, risk-based screening for atrial fibrillation across the European community, using biomarkers and population-level risk stratification.
FONDAZIONE NEUROMED
Italian medical research foundation combining neuroscience expertise with digital cardiovascular screening and European public health research.
Their core work
Fondazione Neuromed is an Italian medical research foundation based in Pozzilli, southern Italy, focused on neurological and cardiovascular disease research. Their scientific work spans from neuroscience and brain health to population-level cardiovascular screening, including digital tools for detecting atrial fibrillation and preventing stroke. Beyond laboratory and clinical research, they have invested in science communication, running programs that introduce young students to neuroscience and European research careers. They operate as both research performers and outreach actors within the broader Italian and European health research ecosystem.
What they specialise in
B-FUTURE (2018-2019) highlighted neuroscience and cyber brain as core themes, reflecting the foundation's neurology-centered research identity.
AFFECT-EU applied digital screening methodologies for population-level atrial fibrillation detection, signaling a shift toward technology-assisted clinical research.
B-FUTURE was a Coordination and Support Action where NEUROMED led efforts to engage young students with neuroscience and European scientific career pathways.
How they've shifted over time
In their earliest H2020 work (2018-2019), NEUROMED focused on science communication and outreach — coordinating a project that brought neuroscience and research career awareness to young students across Europe. By 2020, their focus shifted sharply toward clinical and translational cardiovascular research, joining a large Research and Innovation Action on digital atrial fibrillation screening and population health outcomes. This trajectory suggests a deliberate move from visibility-building toward substantive clinical research participation.
NEUROMED is deepening its clinical research engagement, moving from awareness-raising coordination into data-driven cardiovascular disease screening — a direction that will attract health technology and digital diagnostics collaborators.
How they like to work
NEUROMED has shown flexibility in both leading and following within consortia — coordinating B-FUTURE and participating in AFFECT-EU. Despite only two projects, they have built a notably wide network of 25 partners across 16 countries, suggesting they are well-embedded in European research circles rather than operating in isolation. This breadth points to an organization that brings established credibility and connections, making them a valued consortium member even without a dominant leadership role.
NEUROMED has connected with 25 unique consortium partners across 16 countries through just two projects, indicating strong European network density. Their collaboration footprint spans well beyond Italy, reflecting genuine cross-border research integration.
What sets them apart
As a specialized medical research foundation in southern Italy, NEUROMED occupies an unusual space between clinical neuroscience and public health research — not a large university hospital, not a pure laboratory, but a focused institute with both research capacity and public outreach experience. Their combination of neurology heritage and recent cardiovascular digital screening work makes them a distinctive partner for health technology projects seeking both scientific credibility and patient-facing relevance.
Highlights from their portfolio
- AFFECT-EUA Research and Innovation Action running through 2024, this project positioned NEUROMED within a large European consortium tackling one of the leading causes of stroke through digital population screening — their most clinically impactful H2020 project.
- B-FUTURENEUROMED coordinated this Coordination and Support Action, demonstrating project leadership capacity and their engagement with science-society communication, particularly around neuroscience and European research careers.